DiaMedica Therapeutics, Inc.

  • Home
  • Our Focus
    • Overview
    • Literature & Publications
  • Pipeline
    • Overview
    • Preeclampsia
    • Acute Ischemic Stroke
  • Clinical Trials
    • Overview
    • Preeclampsia
    • Acute Ischemic Stroke
  • ReMEDy2 Trial
    • Overview
    • About ReMEDy2
    • Stroke Disease
    • For Physicians
    • Trial Locations
  • About DiaMedica
    • Overview
    • Leadership
    • Careers
    • Contact
  • Investors Relations
    • Overview
    • Press Releases
    • Events & Presentations
    • Stock Data
    • Analyst Coverage
    • Financial Reports & SEC Filings
    • Governance
    • Resources

Press Releases

Investors Relations

Investors Relations

  • Overview
  • Press Releases
  • Events & Presentations
  • Stock Data
    • Nasdaq Quote
    • Charts
    • Historical Data
  • Analyst Coverage
  • Financial Reports & SEC Filings
    • SEC Filings
    • Annual Reports
    • Tax Information (PFIC)
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Resources
    • Investor Contact
    • FAQ
    • Share Consolidation Instructions
    • Email Alerts
Jan 22, 2024 8:23am EST

DiaMedica Therapeutics Appoints Dr. Lorianne Masuoka as Chief Medical Officer

Nov 13, 2023 4:28pm EST

DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2023 Financial Results

Nov 09, 2023 8:25am EST

DiaMedica Therapeutics to Attend the 14th Annual Craig-Hallum Alpha Select Conference November 16, 2023

Nov 06, 2023 8:23am EST

DiaMedica Therapeutics to Report Third Quarter 2023 Financial Results and Provide a Business Update November 14, 2023

Sep 12, 2023 8:13am EDT

DiaMedica Therapeutics Announces the Appointment of Ambarish Shah, Ph.D. as Chief Technology Officer

Sep 06, 2023 8:35am EDT

DiaMedica Therapeutics to Participate at Lake Street’s 7th Annual Best Ideas Growth Conference

Aug 14, 2023 4:13pm EDT

DiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2023 Financial Results

Aug 08, 2023 8:32am EDT

DiaMedica Therapeutics to Report Second Quarter 2023 Financial Results and Provide a Business Update August 15, 2023

Jul 18, 2023 8:30am EDT

DiaMedica Therapeutics to Attend the American Academy of Neurology Summer Conference

Jun 26, 2023 8:30am EDT

DiaMedica Therapeutics Announces Closing of $37.5 Million Private Placement

  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …16
  • Next
RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
© 2025 DiaMedica Therapeutics, Inc. All Rights Reserved.
Twitter LinkedIn
Privacy Policy Disclaimer Sitemap